The Latin America, Middle East and Africa Flow Cytometry Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Traditional gating systems now have an alternative due to recent developments in automated population identification utilizing computational methodologies. Automated identification techniques may aid in locating rare and secret populations. A dimensionality reduction approach called T-Distributed Stochastic Neighbor Embedding (tSNE) is used to visualize complex multi-dimensional data within a two-dimensional map.
An open program called FlowCAP or Flow Cytometry: Critical Assessment of Population Identification Methods, was created as a result of collaborative efforts. Its goals are to provide an impartial means of comparing and evaluating the flow cytometry data clustering methods as well as to establish guidelines regarding the proper use and application of these methods. A strong tool for cell analysis, flow cytometry can be used for a wide range of tasks, from phenotyping to determining the viability and health of cells.
With more than 70% of the worldwide incidence of infection, Sub-Saharan Africa bears a disproportionate burden of HIV. The success of HIV prevention efforts in sub-Saharan Africa could have an impact on the worldwide HIV burden. Despite significant advancements in scaling up antiretroviral therapy, 74% of the 1.5 million AIDS-related fatalities in 2013 occurred in sub-Saharan Africa. In sub-Saharan Africa, where an estimated 6000 new infections are anticipated to develop daily, young women continue to suffer a disproportionate share of the burden.
The Brazil market dominated the LAMEA Flow Cytometry Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $137.3 million by 2028. The Argentina market is experiencing a CAGR of 12% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 11.1% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Flow Cytometry Market is Predict to reach $7.7 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
By Application
By End User
By Technology
By Component
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
